Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer
DK Lau, J Mencel, I Chau - Expert Opinion on Drug Safety, 2022 - Taylor & Francis
Introduction Anti-angiogenic drugs are an efficacious class of therapy in the treatment of
patients with metastatic colorectal cancer (mCRC). Aflibercept, a vascular endothelial growth …
patients with metastatic colorectal cancer (mCRC). Aflibercept, a vascular endothelial growth …
Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review
X Zou, P Zhou, W Lv, C Liu, J Liu - Frontiers in Pharmacology, 2023 - frontiersin.org
Anlotinib is an oral multi-targeted tyrosine kinase inhibitor as a third-line and subsequent
treatment for patients with small cell lung cancer (SCLC) in China. The neurotoxicity is less …
treatment for patients with small cell lung cancer (SCLC) in China. The neurotoxicity is less …